PACS Group, Inc. (PACS)
NYSE: PACS · Real-Time Price · USD
44.24
-0.15 (-0.34%)
At close: Aug 27, 2026, 4:00 PM EDT
44.10
-0.14 (-0.32%)
After-hours: Aug 27, 2026, 7:50 PM EDT
PACS Group Revenue
PACS Group had revenue of $1.43B in the quarter ending June 30, 2026, with 9.07% growth. This brings the company's revenue in the last twelve months to $5.55B, up 15.15% year-over-year. In the year 2025, PACS Group had annual revenue of $5.29B with 29.32% growth.
Revenue (ttm)
$5.55B
Revenue Growth
+15.15%
P/S Ratio
1.26
Revenue / Employee
$116,975
Employees
47,455
Market Cap
7.00B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.29B | 1.20B | 29.32% |
| Dec 31, 2024 | 4.09B | 978.24M | 31.44% |
| Dec 31, 2023 | 3.11B | 689.50M | 28.47% |
| Dec 31, 2022 | 2.42B | 1.26B | 107.62% |
| Dec 31, 2021 | 1.17B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Fresenius Medical Care AG | 22.19B |
| Universal Health Services | 18.11B |
| DaVita | 14.01B |
| Encompass Health | 6.21B |
| Option Care Health | 5.69B |
| The Ensign Group | 5.49B |
| Aveanna Healthcare Holdings | 2.60B |
| Chemed | 2.60B |
PACS News
- 17 days ago - Pacs Group price target raised to $57 from $48 at Oppenheimer - TheFly
- 21 days ago - Pacs Group price target raised to $60 from $57 at UBS - TheFly
- 21 days ago - Pacs Group price target raised to $62 from $52 at Truist - TheFly
- 21 days ago - Pacs Group price target raised to $57 from $52 at RBC Capital - TheFly
- 22 days ago - PACS Group Earnings Call Transcript: Q2 2026 - Transcripts
- 22 days ago - PACS Group Quarterly report: Q2 2026 - Filings
- 22 days ago - PACS Group Earnings release: Q2 2026 - Filings
- 22 days ago - PACS Group Slides: Q2 2026 - Filings